INO Financial Facts

Total operating expenses: 10.17M
Grant and miscellaneous revenue: 612.9K
See Full Income Statement

Cash and cash equivalents: 70.67M
Total Inovio Pharmaceuticals, Inc. stockholders' equity: 116.73M
See Full Balance Sheet

Inovio Pharma (INO) Earnings

  |   Expand Research on INO
Next EPS Date 3/17/15 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate -9.7% Revenue Growth Rate -81.1% *Last Qtr.
Average % Move 1-Wk after EPS -0.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/10/14 Q314 -$0.12-$0.14 +$0.02$1.8M$5.6M N/A Details
8/11/14 Q214 -$0.18-$0.19 +$0.01$3.8M$1.8M N/A Details
5/12/14 Q114 -$0.05-$0.04 -$0.01$2.4M$1.41M N/A Details
3/17/14 Q413 -$0.04-$0.03 -$0.01$1.7M$1.36M N/A Details
11/12/13 Q313 $0.00-$0.02 +$0.02$9.5M$2.99M N/A Details
8/9/13 Q213 -$0.06N/A N/A $786K$436K N/A Details
3/18/13 Q412 $0.00-$0.04 +$0.04$1.1M$1.08M N/A Details
11/7/12 Q312 -$0.05-$0.05 $0.00$855K$2.07M N/A Details